Cost-effectiveness of routine annual influenza vaccination by age and risk status

CONCLUSIONS: Cost-effectiveness of influenza vaccination varied by age and risk status and was less than $95,000/QALY for all subgroups, except for non-high-risk working-age adults. Results were sensitive to the probability of influenza illness and vaccination was more favorable under certain scenarios. Vaccination for higher risk subgroups resulted in ICERs below $100,000/QALY even at low levels of vaccine effectiveness or circulating virus.PMID:37291022 | DOI:10.1016/j.vaccine.2023.04.069

Source: Vaccine - June 8, 2023 Category: Allergy & Immunology Authors: Ellen Kim DeLuca Acham Gebremariam Angela Rose Matthew Biggerstaff Martin I Meltzer Lisa A Prosser Source Type: research